Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. With their approach, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, completing them up to three times faster than conventional CROs and often delivering results ahead of schedule.

Creandum

Salica

Seedcamp

Amino Collective

Peter Thiel

First Minute Capital

Presight Capital

UK Research and Innovation

Biotechnology

Healthcare

Lindus Health

NEW YORK, June 27, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has unveiled their all-encompassing contract research organization (CRO) and technology solution customized for the execution of medical device clinical trials.Lindus Health has enrolled over 11,000 medical device trial participants to date in the US, UK, and Europe, and has demonstrated consistent success in executing device studies across virtually all therapeutic areas, including neurology, ophthalmology, cardiovascular, respiratory, and more. This covers many device types including Class I (low-risk) and Class II (moderate-risk) devices, diagnostics and others, as well as regulatory pathways such as premarket approval (PMA) and Conformité Européenne (CE) marking. With the introduction of their "All-in-One Medical Device CRO," Lindus will accelerate and enhance clinical trials for medical devices, pulling from their robust resume in device development.Lindus Health's new offering integrates traditional CRO services and comprehensive experience in medical device clinical trials. Additionally, they have unique recruitment capabilities by utilizing their database of over 30 million electronic health records (EHRs) and or in-house digital marketing. This offering also includes their home-grown eClinical technology, Citrus™. Lindus offers extensive in-house site capabilities including their own virtual/hybrid site and physical community site networks

Lindus Health Launches Bespoke "All-In-One Medical Device Cro" Offering For Medical Device Clinical Trials

NEW YORK, May 29, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-encompassing contract research organization (CRO) unique to consumer health companies seeking clinical validation for their products.To date, Lindus Health has conducted numerous end-to-end trials in consumer health and wellness, enrolling patients across the US, UK, and Europe for a variety of products including topical creams, prebiotics and probiotics, weight loss supplements, digital health interventions, over-the-counter medications, and more. Lindus Health is set to enhance consumer health trials with the release of their "All-in-One Consumer Health CRO", capitalizing on their expertise in the development of health and wellness products.Lindus Health's new offering merges expert CRO services and vast experience in consumer health clinical trials with a database of over 30 million electronic health records (EHRs) and their proprietary eClinical platform, Citrus™. This comprehensive solution provides companies developing health and wellness products with all the tools they need to conduct their research in one place.Clinical trials for consumer health products must be proven to be effective among the general population, rather than just individuals with a specific medical diagnosis. Lindus Health's offering equips sponsors to enroll diverse participant populations through a variety of tactics, including targeted social media recruitment campaigns, collaborations with primary care, EHR screening, virtual and hybrid site models, and more. The company's robust recruitment capabilities allow them to enroll participants in consumer health trials two times faster on average."People are prioritizing health and wellness today more than ever before and want to ensure the products they use in their everyday lives are safe and effective," said Lindus Health co-founder, Meri Beckwith. "The launch of our 'All-in-One Consumer Health CRO' offering provides consumer health companies with a streamlined, cost-effective approach to obtain clinical validation and support health claims."The "All-in-One Consumer Health CRO" solution provides consumer health companies with a comprehensive suite of features:CRO and traditional study management services: Lindus Health's clinical operations team leverages their extensive expertise in health and wellness research through trial end-to-end execution, from study startup through close-out.Lindus Health's clinical operations team leverages their extensive expertise in health and wellness research through trial end-to-end execution, from study startup through close-out

Lindus Health Introduces "All-In-One Consumer Health Cro" Offering Tailored To Clinical Trials For Consumer Health Products

Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has launched an all-encompassing contract research organization (CRO) unique to consumer health companies seeking clinical validation for their products.To date, Lindus Health has conducted numerous end-to-end trials in consumer health and wellness, enrolling patients across the US, UK, and Europe for a variety of products including topical creams, prebiotics and probiotics, weight loss supplements, digital health interventions, over-the-counter medications, and more. Lindus Health is set to enhance consumer health trials with the release of their “All-in-One Consumer Health CRO”, capitalizing on their expertise in the development of health and wellness products.Lindus Health’s new offering merges expert CRO services and vast experience in consumer health clinical trials with a database of over 30 million electronic health records (EHRs) and their proprietary eClinical platform, Citrus™. This comprehensive solution provides companies developing health and wellness products with all the tools they need to conduct their research in one place.Clinical trials for consumer health products must be proven to be effective among the general population, rather than just individuals with a specific medical diagnosis. Lindus Health’s offering equips sponsors to enroll diverse participant populations through a variety of tactics, including targeted social media recruitment campaigns, collaborations with primary care, EHR screening, virtual and hybrid site models, and more. The company’s robust recruitment capabilities allow them to enroll participants in consumer health trials two times faster on average.“People are prioritizing health and wellness today more than ever before and want to ensure the products they use in their everyday lives are safe and effective,” said Lindus Health co-founder, Meri Beckwith. “The launch of our ‘All-in-One Consumer Health CRO’ offering provides consumer health companies with a streamlined, cost-effective approach to obtain clinical validation and support health claims.”The “All-in-One Consumer Health CRO” solution provides consumer health companies with a comprehensive suite of features:CRO and traditional study management services: Lindus Health’s clinical operations team leverages their extensive expertise in health and wellness research through trial end-to-end execution, from study startup through close-out.Lindus Health’s clinical operations team leverages their extensive expertise in health and wellness research through trial end-to-end execution, from study startup through close-out

Lindus Health Introduces “All-In-One Consumer Health Cro” Offering Tailored To Clinical Trials For Consumer Health Products

Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne. NEWS PROVIDED BY. Lindus Health

Lindus Health Announces Cosmetics Clinical Trial With Acinonyx Bio To Evaluate An Alternative To Benzoyl Peroxide For Inflammatory Acne

NEW YORK, May 8, 2024 /PRNewswire/ -- Lindus Health, an anti-CRO running radically faster, more reliable clinical trials for life science pioneers, is announcing the appointment of Dr. Tim Garnett, pharma industry leader and former Chief Medical Officer at Eli Lilly, to their advisory board. This significant move follows closely on the heels of the company's previous addition of advisor Dr. Robert Langer, Institute Professor of Massachusetts Institute of Technology (MIT), and co-founder of Moderna, Inc.Dr. Garnett is a board member of leading biotechs like Maplight Therapeutics and Ophirex, Inc. , as well as an advisor to Ukko and Biolojic Design

Dr. Tim Garnett, Former Chief Medical Officer Of Eli Lilly, Joins Lindus Health'S Advisory Board

Site location, community reflective advertising, translation of study materials and social media outreach among the top methodsNEW YORK, May 2, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, announced the results of a study examining the motivators and deterrents of clinical trial participation among ethnic minorities. The research paper, published in MedRxiv , outlines strategies sponsors can utilize to minimize deterrents and promote diversity in their research.Lindus Health partnered with the University of Oxford in a collaborative effort to conduct a qualitative study aimed at investigating perceptions regarding participation in clinical research. The study collected data from both research professionals and the general population through eSurveys, meticulously crafted with guidance from the Enhancing Diversity in Clinical Trials (EDICT) advisory committee. Additionally, focus groups were conducted with members of the general population who were provided with preparatory educational materials beforehand then later invited to share their perspectives on engaging in clinical trials, with a particular focus on distinguishing between early phase and later phase research. To ensure a diverse representation in the study cohort, social media recruitment strategies were also employed.While the majority of respondents of the general population surveys had never engaged in clinical research to date, Black individuals reported to be more willing to participate in a trial (including early phase research) than Asian. The top three barriers to participation overall, regardless of study phase, included safety and health concerns, time investment, and lack of support

Lindus Health And University Of Oxford Publish Study Citing Key Strategies To Foster Diversity In Clinical Trial Participation

NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched their "all-in-one" contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.Cardiovascular disease is the leading cause of death in both men and women as well as most racial groups in the US. Clinical trials for these conditions require large, diverse participant populations to capture variability in disease presentation and risk factors, along with extended follow-up to assess long-term outcomes and quality of life improvements. Implementing patient-centric approaches in these studies, like remote-monitoring or decentralized trial designs, is also critical to reduce barriers to participation and observe how these interventions perform in the real world. Lindus Health's latest offering equips sponsors with all the necessary resources to navigate these distinct challenges and more that come with conducting clinical trials in the cardiovascular space.To date, Lindus Health has enrolled over 8,000 patients in cardiovascular studies across the US, UK, and EU. Their "All-in-One Cardiovascular CRO" includes end-to-end CRO and site services, industry knowledge, and eClinical technology necessary for sponsors developing therapies and devices to treat and monitor cardiovascular indications."Patient experience is paramount in cardiovascular studies," said Meri Beckwith, co-founder at Lindus Health

Lindus Health Releases "All-In-One Cardiovascular Cro" Offering For Clinical Trials Serving Cardiovascular Health

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has introduced their versatile contract research organization (CRO), site, and technology offering tailor-made to the execution of infectious disease trials.Clinical development of infectious disease treatments and diagnostics must account for complexities such as diverse and evolving pathogens, seasonality and localization of study sites, and enrollment at the appropriate time during infection. Having enrolled over 5,000 patients in infectious disease studies across the US, EU, and UK, Lindus Health is well-equipped to handle the unique challenges within this therapeutic area.Lindus Health's latest solution for the infectious disease market segment leverages their full-spectrum CRO and site services, rooted in deep expertise in running infectious disease clinical trials. They are able to recruit diverse study populations at twice the speed of traditional CROs through their expansive recruitment capabilities, including targeted digital outreach campaigns, healthcare and community organization collaborations, and electronic health record (EHR) screening from a repository of over 30 million patients."Infectious disease studies require swift and adaptable approaches for execution and recruitment to keep pace with evolving pathogens and public health needs," said Meri Beckwith, co-founder of Lindus Health. "Therefore speed of execution and access to real-time data are essential, while ensuring enrollment of diverse and representative patient populations."The "All-in-One Infectious Disease CRO" offers a comprehensive suite of resources and services to support infectious disease research, including:Full-service CRO solutions: From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities.From protocol writing and study startup to close-out and data delivery, Lindus Health's clinical operations team oversees all aspects of infectious disease trials, handling all project management and administrative responsibilities. Innovative recruitment strategies : With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies.: With partnerships across primary care, urgent care, and local community groups as well as EHR screening and direct-to-patient marketing, Lindus employs advanced methods to quickly recruit diverse patient populations in infectious disease studies

Lindus Health Rolls Out "All-In-One Infectious Disease Cro" Bespoke To Clinical Trials For Infectious Disease Interventions

A new study from the University of Cambridge suggests artificial intelligence (AI) could significantly accelerate the detection of antibiotic-resistant bacteria. Published in Nature Communications, the research demonstrates a machine-learning model capable of identifying drug-resistant Salmonella Typhimurium from microscope images, potentially reducing diagnosis time compared to traditional methods. It’s part of a growing push to use AI to detect disease and find new drugs for treatments. “We believe there is huge potential for better diagnostics to radically change healthcare and pharma,”   Meri Beckwith, co-founder of Lindus Health, a company focused on accelerating clinical trials that was not involved in the Cambridge study, told PYMNTS

Ai Offers Quicker Detection Of Drug-Resistant Bacteria

NEW YORK, July 9, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Aktiia, the pioneering blood pressure intelligence startup offering non-invasive and cuffless continuous blood pressure monitoring, have announced the launch of their clinical trial to evaluate user satisfaction with Aktiia's optical blood pressure monitoring (OBPM) device in hypertensive individuals.Hypertension, or high blood pressure, is estimated to affect over 1.3 billion adults globally, and is the leading cause of heart disease, stroke, kidney disease, and many other diseases. Devices that continuously monitor blood pressure can offer valuable insights into hypertension severity, treatment efficacy, and fluctuations related to daily activity, lifestyle, and sleep patterns.This study will examine user experience with Aktiia's non-invasive, cuffless OPBM device. The device, worn as a bracelet, measures blood pressure continuously using optical sensors, offering a more convenient alternative to traditional blood pressure cuffs. In addition to measuring satisfaction with the device, the trial will also observe the evolution of participants' blood pressure over the study period and correlate this data with sociodemographic, lifestyle, and health factors.Lindus Health and Aktiia will enroll 7,500 participants with known hypertension in this 12-week clinical trial. Lindus Health will provide end-to-end study management, including protocol development, regulatory submissions, recruitment, monitoring, and data management. They will utilize their in-house virtual site and digital marketing capabilities for patient recruitment through digital advertising as well as primary care screening and patient community outreach

Lindus Health And Aktiia To Launch Observational Clinical Trial For Aktiia'S Optical Blood Pressure Monitoring Device

Accelerates clinical trials for life sciences

Lindus Health

Accelerates clinical trials for life sciences

Lindus Health

Accelerates clinical trials for life sciences

About

Simplify's Take

What believers are saying

What critics are saying

What makes Lindus Health unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Lindus Health is Hiring for 0 Jobs on Simplify!